Acute Treament of Tension-Type Headache (TTH)
Posted on October 04 2022,

This post is for educational purposes only and may contain errors. Please talk to your neurologist.
Studies aren’t as ubiquitous for tension-type headache (TTH) acute treatment as they are for migraine treatment.
Due to this, we draw some conclusions from the studies on migraine treatment. For example, it is theorized that taking abortive therapy early in the treatment of TT will result in a better outcome than if abortive therapy was given later during the condition due to studies with abortive therapy and migraines.
There are a few principles that are important in terms of treating TTH:
- As you have read earlier, the earlier the treatment, the better (we think).
- Start with the highest dose of the medication of choice to limit having to take more doses later (Again, we think. It is likely more variable and dependent on the patient’s response to said medication).
- Simple analgesics have little to no benefit with chronic TTH. That is episodes of≥ 15 days per month on average for ≥ 3 months (≥ 180 days per year). Episodic TTH often becomes chronic.
- It is important to limit the frequency of analgesic use due to medication overuse headache. More on this here: https://www.cerebraltorque.com/blogs/migranews/medication-overuse-headache-moh-treatment-has-changed-mots-medication-overuse-treatment-strategy-trial
First-line therapy:
NSAIDs > Acetaminophen due to effectiveness (some experts consider acetaminophen to be first line). Choice should be made based on comorbid conditions and/or pregnancy (where acetaminophen is the drug of choice).
NSAID agents include:
- Ibuprofen 200 or 400 mg
- Naproxen 220 or 550 mg
- Aspirin 650 to 1000 mg
- (not available OTC) Ketoprofen 25 or 50 mg
- (alternative) diclofenac 25 to 100 mg
Acetaminophen, the initial therapy of TTH for pregnancy, is taken as a single dose of 1000 mg.
To determine treatment effectiveness, employ migraine criteria. See: https://pubmed.ncbi.nlm.nih.gov/25139586/
In case of treatment failure, consider other potential possibilities (i.e., wrong diagnosis, medication overuse headache, etc.)
Consider cervicogenic headache if the pain is unilateral. Consider migraine without aura. Consider medication overuse headache if simple analgesics were taken >15 days/month or combination analgesics or triptans for > 10 days/month. Consider other types of headaches.
Second-line therapy:
Combination analgesics containing caffeine. (Most popular OTC is Excedrin).
For clinical setting (parenteral medications):
- Metoclopramide
- Metoclopramide plus diphenhydramine
- Chlorpromazine
- IM ketorolac
Combination analgesics containing butalbital and codeine are not recommended
Muscle relaxants are not recommended. No good randomized controlled trials evaluating muscle relaxants for the treatment of tension-type headache. They are also not considered effective and have a risk of dependence.
https://pubmed.ncbi.nlm.nih.gov/20482606/
Triptans
TTH occurring in migraineurs may respond to triptans.
Fri, Apr 25, 25
Evidence-Based Guidelines for the Pharmacological Treatment of Migraine (Updated April 2025)
Discover evidence-based guidelines for migraine treatment from leading experts. Learn about effective medications for acute attacks and prevention, their evidence quality, and recommendation strength to better manage your migraines.
Read MoreThu, Apr 24, 25
Clinical Predictors for Efficacy of Erenumab (Aimovig) for Migraine
Discover key predictors of Aimovig (erenumab) response in migraine patients. This REFORM study reveals which patients benefit most from CGRP therapy and why timing matters. Evidence-based insights for better treatment...
Read MoreWed, Apr 23, 25
Effectiveness and Tolerability of Atogepant (Qulipta) in the Prevention of Migraine
STAR study shows atogepant (Qulipta) effectively reduces migraine days by 56.6% in real-world clinical practice, even for patients with previous treatment failures. Learn about this breakthrough.
Read More